The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis
Open accessAbstract
Objective: To develop recommendations for the screening, monitoring, and treatment of uveitis in children with juvenile idiopathic arthritis ( JIA ). Methods: Pediatric rheumatologists, ophthalmologists with expertise in uveitis, patient representatives, and methodologists generated key clinical questions to be addressed by this guideline. This was followed by a systematic literature review and rating of the available evidence according to the GRADE (Grading of Recommendations Assessment, Development and Evaluation) methodology. A group consensus process was used to compose the final recommendations and grade their strength as conditional or strong. Results: Due to a lack of literature with good quality of evidence, recommendations were formulated on the basis of available evidence and a consensus expert opinion. Regular ophthalmic screening of children with JIA is recommended because of the risk of uveitis, and the frequency of screening should be based on individual risk factors. Regular ophthalmic monitoring of children with uveitis is recommended, and intervals should be based on ocular examination findings and treatment regimen. Ophthalmic monitoring recommendations were strong primarily because of concerns of vision‐threatening complications of uveitis with infrequent monitoring. Topical glucocorticoids should be used as initial treatment to achieve control of inflammation. Methotrexate and the monoclonal antibody tumor necrosis factor inhibitors adalimumab and infliximab are recommended when systemic treatment is needed for the management of uveitis. The timely addition of nonbiologic and biologic drugs is recommended to maintain uveitis control in children who are at continued risk of vision loss. Conclusion: This guideline provides direction for clinicians and patients/parents making decisions on the screening, monitoring, and management of children with JIA and uveitis, using GRADE methodology and informed by a consensus process with input from rheumatology and ophthalmology experts, current literature, and patient/parent preferences and values.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
(2005) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.03.057 · Cited by 4,396
Ravelli, A., & Martini, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60363-8 · Cited by 1,993
GRADE guidelines: 2. Framing the question and deciding on important outcomes
Guyatt, G. H., Oxman, A. D., Kunz, R., Atkins, D., Brozek, J., Vist, G., Alderson, P., Glasziou, P., Falck-Ytter, Y., & Schünemann, H. J. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.09.012 · Cited by 1,911
Andrews, J., Guyatt, G., Oxman, A. D., Alderson, P., Dahm, P., Falck-Ytter, Y., Nasser, M., Meerpohl, J., Post, P. N., Kunz, R., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.03.013 · Cited by 1,416
Andrews, J. C., Schünemann, H. J., Oxman, A. D., Pottie, K., Meerpohl, J. J., Coello, P. A., Rind, D., Montori, V. M., Brito, J. P., Norris, S., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.02.003 · Cited by 1,315
Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive
Jaeschke, R., Guyatt, G. H., Dellinger, P., Schunemann, H., Levy, M. M., Kunz, R., Norris, S., Bion, J., & for the GRADE working group (2008) · BMJ · doi:10.1136/bmj.a744 · Cited by 577
Levy-Clarke, G., Jabs, D. A., Read, R. W., Rosenbaum, J. T., Vitale, A., & Van Gelder, R. N. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2013.09.048 · Cited by 483
Ringold, S., Angeles‐Han, S. T., Beukelman, T., Lovell, D., Cuello, C. A., Becker, M. L., Colbert, R. A., Feldman, B. M., Ferguson, P. J., Gewanter, H., et al. (2019) · Arthritis Care & Research · doi:10.1002/acr.23870 · Cited by 462
Self-citationAdalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis
Ramanan, A. V., Dick, A. D., Jones, A. P., McKay, A., Williamson, P. R., Compeyrot-Lacassagne, S., Hardwick, B., Hickey, H., Hughes, D., Woo, P., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1614160 · Cited by 437
Juvenile Idiopathic Arthritis: Will Etanercept be an Improvement over Current Therapies?
De Benedetti, F., & Ravelli, A. (2000) · BioDrugs · doi:10.2165/00063030-200014020-00003 · Cited by 428
Acute Anterior Uveitis and HLA-B27
Chang, J. H., McCluskey, P. J., & Wakefield, D. (2005) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2005.04.003 · Cited by 365
Acute anterior uveitis and HLA-B27
Wakefield, D., Montanaro, A., & Cluskey, P. M. (1991) · Survey of Ophthalmology · doi:10.1016/0039-6257(91)90005-z · Cited by 351
Epidemiology and Course of Disease in Childhood Uveitis
Smith, J. A., Mackensen, F., Sen, H. N., Leigh, J. F., Watkins, A. S., Pyatetsky, D., Tessler, H. H., Nussenblatt, R. B., Rosenbaum, J. T., Reed, G. F., et al. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2009.05.002 · Cited by 341
Self-citationOcular complications of pediatric uveitis
Rosenberg, K. D., Feuer, W. J., & Davis, J. L. (2004) · Ophthalmology · doi:10.1016/j.ophtha.2004.06.014 · Cited by 282
Thorne, J. E., Woreta, F., Kedhar, S. R., Dunn, J. P., & Jabs, D. A. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.01.033 · Cited by 242
Favorable Response to High-Dose Infliximab for Refractory Childhood Uveitis
Kahn, P., Weiss, M., Imundo, L. F., & Levy, D. M. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.01.005 · Cited by 210
Constantin, T., Foeldvari, I., Anton, J., de Boer, J., Czitrom-Guillaume, S., Edelsten, C., Gepstein, R., Heiligenhaus, A., Pilkington, C. A., Simonini, G., et al. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-213131 · Cited by 209
Tynjälä, P., Lindahl, P., Honkanen, V., Lahdenne, P., & Kotaniemi, K. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.058248 · Cited by 206
Prognostic Factors in the Uveitis of Juvenile Rheumatoid Arthritis
Wolf, M. D., Lichter, P. R., & Ragsdale, C. G. (1987) · Ophthalmology · doi:10.1016/s0161-6420(87)80007-6 · Cited by 205
Gregory, A. C., Kempen, J. H., Daniel, E., Kaçmaz, R. O., Foster, C. S., Jabs, D. A., Levy-Clarke, G. A., Nussenblatt, R. B., Rosenbaum, J. T., Suhler, E. B., et al. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2012.07.052 · Cited by 182
Zulian, F., Balzarin, M., Falcini, F., Martini, G., Alessio, M., Cimaz, R., Cimino, L., & Zannin, M. E. (2010) · Arthritis Care & Research · doi:10.1002/acr.20115 · Cited by 179
Clinical Features and Associated Systemic Diseases of HLA-B27 Uveitis
TAY-KEARNEY, M.-L., SCHWAM, B. L., LOWDER, C., DUNN, J. P., MEISLER, D. M., VITALE, S., & JABS, D. A. (1996) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)70533-1 · Cited by 162
Calvo‐Río, V., Santos‐Gómez, M., Calvo, I., González‐Fernández, M. I., López‐Montesinos, B., Mesquida, M., Adán, A., Hernández, M. V., Maíz, O., Atanes, A., et al. (2017) · Arthritis & Rheumatology · doi:10.1002/art.39940 · Cited by 159
Heiligenhaus, A., Michels, H., Schumacher, C., Kopp, I., Neudorf, U., Niehues, T., Baus, H., Becker, M. D., Bertram, B., Dannecker, G. E., et al. (2011) · Rheumatology International · doi:10.1007/s00296-011-2126-1 · Cited by 150
Self-citationChia, A., Lee, V., GRAHAM, E. M., et al. (2003) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(03)00225-3 · Cited by 131
Sobrin, L., Christen, W., & Foster, C. S. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.12.011 · Cited by 131
Chronic Anterior Uveitis in Children: Clinical Characteristics and Complications
Holland, G. N., Denove, C. S., & Yu, F. (2009) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2008.11.009 · Cited by 128
Self-citationTappeiner, C., Mesquida, M., Adán, A., Antón, J., Ramanan, A. V., Carreño, E., Mackensen, F., Kotaniemi, K., de Boer, J. H., Bou, R., et al. (2016) · The Journal of Rheumatology · doi:10.3899/jrheum.160231 · Cited by 121
Relapse Rate of Uveitis Post-Methotrexate Treatment in Juvenile Idiopathic Arthritis
Ayuso, V. K., van de Winkel, E. L., Rothová, A., et al. (2010) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2010.08.021 · Cited by 114
Klotsche, J., Niewerth, M., Haas, J., Huppertz, H., Zink, A., Horneff, G., & Minden, K. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-annrheumdis-2014-206747 · Cited by 107
Angeles‐Han, S. T., Lo, M. S., Henderson, L. A., Lerman, M. A., Abramson, L. S., Cooper, A. M., Parsa, M. F., Zemel, L. S., Ronis, T., Beukelman, T., et al. (2018) · Arthritis Care & Research · doi:10.1002/acr.23610 · Cited by 95
Self-citationSaurenmann, R. K., Levin, A. V., Feldman, B. M., Laxer, R. M., Schneider, R., & Silverman, E. D. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.08.044 · Cited by 91
Self-citationThe Risk of Intraocular Pressure Elevation in Pediatric Noninfectious Uveitis
Kothari, S., Foster, C. S., Pistilli, M., Liesegang, T. L., Daniel, E., Sen, H. N., Suhler, E. B., Thorne, J. E., Jabs, D. A., Levy-Clarke, G. A., et al. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2015.06.041 · Cited by 82
Self-citationBirolo, C., Zannin, M. E., Arsenyeva, S. V., Cimaz, R., Miserocchi, E., Dubko, M. F., Job-Deslandre, C., Falcini, F., Alessio, M., Torre, F. L., et al. (2016) · The Journal of Rheumatology · doi:10.3899/jrheum.151389 · Cited by 66
High Doses of Infliximab in the Management of Juvenile Idiopathic Arthritis
Tambralli, A., Beukelman, T., Weiser, P., Atkinson, T. P., Cron, R. Q., & Stoll, M. L. (2013) · The Journal of Rheumatology · doi:10.3899/jrheum.130133 · Cited by 62
Self-citationUveitis Reactivation in Children Treated With Tumor Necrosis Factor Alpha Inhibitors
Lerman, M. A., Lewen, M. D., Kempen, J. H., et al. (2015) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2015.04.016 · Cited by 48
for the CARRA Registry Investigators, Henderson, L. A., Zurakowski, D., Angeles‐Han, S. T., Lasky, A., Rabinovich, C. E., & Lo, M. S. (2016) · Pediatric Rheumatology · doi:10.1186/s12969-016-0069-5 · Cited by 44
Self-citationBreitbach, M., Tappeiner, C., Böhm, M. R. R., et al. (2016) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-016-3497-5 · Cited by 19
Musson, D. G., Bidgood, A. M., & Olejník, O. (1992) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.1992.8.139 · Cited by 18
Cited by
Ringold, S., Angeles‐Han, S. T., Beukelman, T., Lovell, D., Cuello, C. A., Becker, M. L., Colbert, R. A., Feldman, B. M., Ferguson, P. J., Gewanter, H., et al. (2019) · Arthritis Care & Research · doi:10.1002/acr.23870 · Cited by 462
Self-citationMartini, A., Lovell, D. J., Albani, S., Brunner, H. I., Hyrich, K. L., Thompson, S. D., & Ruperto, N. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00332-8 · Cited by 289
Self-citation
Metadata
- Authors
- Angeles‐Han, S. T., Ringold, S., Beukelman, T., Lovell, D., Cuello, C. A., Becker, M. L., Colbert, R. A., Feldman, B. M., Holland, G. N., Ferguson, P. J., Gewanter, H., Guzman, J., Horonjeff, J., Nigrovic, P. A., Ombrello, M. J., Passo, M. H., Stoll, M. L., Rabinovich, C. E., Sen, H. N., Schneider, R., Halyabar, O., Hays, K., Shah, A. A., Sullivan, N., Szymanski, A. M., Turgunbaev, M., Turner, A., & Reston, J.
- Venue
- Arthritis Care & Research
- Publisher
- Wiley
- Published
- 2019-04-25
- Volume
- 71
- Issue
- 6
- Pages
- 703-716
- ISSN
- 0893-7524 (ISSN-L)
- 2151-464X
- 2151-4658
- OpenAlex
- W2941455980
- Cited by
- 316
- References
- 40
- FWCI
- 32.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.